Interleukin-7-loaded oncolytic adenovirus improves CAR-T cell therapy for glioblastoma
Sign Up to like & getrecommendations! Published in 2021 at "Cancer Immunology, Immunotherapy"
DOI: 10.1007/s00262-021-02856-0
Abstract: T cell with chimeric antigen receptors (CAR-T) has presented remarkable efficacy for blood cancer as an emerging immunotherapy. However, for solid tumors, the therapeutic efficacy is much impaired due to the lack of infiltration and… read more here.
Keywords: il7; efficacy; loaded oncolytic; oad il7 ... See more keywords